IL17A and hypertensive disorder: Studies have shown that inhibiting DNMT activity can significantly reduce the proliferation of Th1 and Th17 cells and suppress the secretion of pro-inflammatory cytokines, such as IFN-γ and IL-17, thereby alleviating chronic inflammation in hypertension (61).